Naloxone hydrochloride; oxycodone hydrochloride - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
What are the generic sources for naloxone hydrochloride; oxycodone hydrochloride and what is the scope of patent protection?
Naloxone hydrochloride; oxycodone hydrochloride
is the generic ingredient in one branded drug marketed by Purdue Pharma Lp and is included in one NDA. There are fifteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.Naloxone hydrochloride; oxycodone hydrochloride has three hundred and four patent family members in forty-four countries.
Summary for naloxone hydrochloride; oxycodone hydrochloride
| International Patents: | 304 |
| US Patents: | 15 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 50 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for naloxone hydrochloride; oxycodone hydrochloride |
| DailyMed Link: | naloxone hydrochloride; oxycodone hydrochloride at DailyMed |
Recent Clinical Trials for naloxone hydrochloride; oxycodone hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ensysce Biosciences | Phase 1 |
| Dr. Vince Clinical Research | Phase 1 |
| National Institute on Drug Abuse (NIDA) | N/A |
See all naloxone hydrochloride; oxycodone hydrochloride clinical trials
US Patents and Regulatory Information for naloxone hydrochloride; oxycodone hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for naloxone hydrochloride; oxycodone hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | ⤷ Sign Up | ⤷ Sign Up |
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-003 | Jul 23, 2014 | ⤷ Sign Up | ⤷ Sign Up |
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | ⤷ Sign Up | ⤷ Sign Up |
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | ⤷ Sign Up | ⤷ Sign Up |
| Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for naloxone hydrochloride; oxycodone hydrochloride
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Germany | 20321531 | ⤷ Sign Up | |
| Australia | 2002305559 | ⤷ Sign Up | |
| Germany | 602005026786 | ⤷ Sign Up | |
| Costa Rica | 20110376 | PROCESO PARA PREPARAR CLORHIDRATO DE OXICODONA TENIENDO MENOS DE UN 25 PPM 14-HYDROXYCODEINA (DIVISIONAL EXP. 8593) | ⤷ Sign Up |
| European Patent Office | 2316428 | Matrices pour liberation modifee des agents actives (Matrix for sustained, invariant and independent release of active compounds) | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for naloxone hydrochloride; oxycodone hydrochloride
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
